Feed aggregator

Securities Fraud Investigation Into SunPower Inc. (SPWR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SunPower Inc. (“SunPower” or the “Company”) (NASDAQ: SPWR) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SUNPOWER INC. (SPWR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On April 14,

Securities Fraud Investigation Into Veritone, Inc. (VERI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON VERITONE, INC. (VERI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On March 26, 2

Deadline Alert: Stellantis N.V. (STLA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) common stock between February 26, 2025 and February 5, 2026, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR STELLANTIS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING

Deadline Soon: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming April 21, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON CORCEPT THERAPEUTICS INCORPORATED (CORT), CL

Wipro Announces Results for the Quarter and Year Ended March 31, 2026

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
EAST BRUNSWICK, N.J. & BANGALORE, India--(BUSINESS WIRE)---- $WIPRO #AI--Wipro Limited announced financial results under International Financial Reporting Standards (IFRS) for the quarter and year ended March 31, 2026.

PPG highlights 2025 performance during annual meeting of shareholders

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today held its annual meeting of shareholders where Tim Knavish, PPG chairman and chief executive officer, highlighted the company’s 2025 performance. PPG achieved $15.9 billion in net sales, including a 2% increase in organic sales due to higher sales volumes and selling prices in all four quarters. This above-market performance was led by sales volume growth in the Performance Coatings segment in the Aerospace Coatings, Protective and Marine Coating

Wolters Kluwer Extends Digital Lending Momentum by Enabling Liquidity Access for Commercial Assets

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
NEW YORK--(BUSINESS WIRE)--Building on its recent expansion of secured party access and digital collateral visibility, Wolters Kluwer Financial & Corporate Compliance today announced support and coordination with the Federal Home Loan Bank of Des Moines (FHLB Des Moines) following its decision to accept digital Commercial Real Estate (CRE), Ag Real Estate, multifamily, HELOC, and other electronic assets as pledged collateral. This collaboration enables member banks and credit unions to digi

rYojbaba Investor News: Rosen Law Firm Encourages rYojbaba Co., Ltd. Investors to Inquire About Securities Class Action Investigation – RYOJ

Lastest from Businesswire - Thu, 04/16/2026 - 14:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of rYojbaba Co., Ltd. (NASDAQ: RYOJ) resulting from allegations that rYojbaba may have issued materially misleading business information to the investing public. So what: If you purchased rYojbaba securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement

Rosen Law Firm Encourages Caring Brands Inc. Investors to Inquire About Securities Class Action Investigation – CABR

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Caring Brands Inc. (NASDAQ: CABR) resulting from allegations that Caring Brands may have issued materially misleading business information to the investing public. So what: If you purchased Caring Brands securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a

Robot Consulting Investor News: Rosen Law Firm Encourages Robot Consulting Co., Ltd. Investors to Inquire About Securities Class Action Investigation – LAWR

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Robot Consulting Co., Ltd. (NASDAQ: LAWR) resulting from allegations that Robot Consulting may have issued materially misleading business information to the investing public. So what: If you purchased Robot Consulting securities you may be entitled to compensation without payment of any out of pocket fees or costs through a con

Slash Achieves Unicorn Status Following $100m Series C Fundraise

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
SAN FRANCISCO--(BUSINESS WIRE)--Slash Financial, Inc., the banking platform1 built for modern businesses, is now valued at $1.4 billion following a $100m Series C funding round led by Ribbit Capital. New investor Khosla Ventures and Goodwater Capital, who led Slash’s Series B just 16 months ago, co-led the round. This latest funding elevates Slash to unicorn status and brings the total amount of capital raised to more than $160 million. New Enterprise Associates and Y Combinator also participat

Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – CURX

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) resulting from allegations that Curanex may have issued materially misleading business information to the investing public. So what: If you purchased Curanex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr

Rosen Law Firm Encourages Megan Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – MGN

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Megan Holdings Ltd. (NASDAQ: MGN) resulting from allegations that Megan Holdings may have issued materially misleading business information to the investing public. So what: If you purchased Megan Holdings securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee

Rosen Law Firm Encourages Propanc Biopharma Inc. Investors to Inquire About Securities Class Action Investigation – PPCB

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Propanc Biopharma Inc. (NASDAQ: PPCB) resulting from allegations that Propanc may have issued materially misleading business information to the investing public. So what: If you purchased Propanc securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangeme

Rosen Law Firm Encourages Elite Express Holding Inc. Investors to Inquire About Securities Class Action Investigation – ETS

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Elite Express Holding Inc. (NASDAQ: ETS) resulting from allegations that Elite Express may have issued materially misleading business information to the investing public. So what: If you purchased Elite Express securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc

ReSource Pro Launches M&A Integration Suite to Help Insurance Agencies Navigate Post-Acquisition Complexities

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--ReSource Pro, a leader in operations, analytics, and technology solutions for the insurance industry, today announced the launch of its Mergers & Acquisitions (M&A) Integration Suite, a structured set of offerings and resources designed to help insurance agencies manage the operational complexity that follows an acquisition. As part of ReSource Pro's Technology Services portfolio, the M&A Integration Suite draws on specialized experts who bring both insura

Beyond Risk Expands with Launch of Beyond Health Partners, Unifying Stop-Loss, Captive, and Cost-Containment Capabilities

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
MCKINNEY, Texas & BEVERLY, Mass.--(BUSINESS WIRE)--Beyond Risk launches Beyond Health Partners, unifying stop-loss, captive, and cost-containment solutions for mid-market employers.

PPG Board of Directors announce quarterly dividend of 71 cents per share

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
PITTSBURGH--(BUSINESS WIRE)--The Board of Directors of PPG (NYSE:PPG) today declared a regular quarterly dividend of 71 cents per share, payable June 12 to shareholders of record May 11. Through the ongoing dedication and engagement of its workforce, PPG has raised its annual dividend payment for 54 consecutive years and has paid uninterrupted annual dividends since 1899. This marks the company’s 511th consecutive dividend payment. PPG: WE PROTECT AND BEAUTIFY THE WORLD® At PPG (NYSE:PPG), we w

Rosen Law Firm Encourages Kandal M Venture Ltd. Investors to Inquire About Securities Class Action Investigation – FMFC

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kandal M Venture Ltd. (NASDAQ: FMFC) resulting from allegations that Kandal may have issued materially misleading business information to the investing public. So what: If you purchased Kandal securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Apimeds Pharmaceuticals Investor News: Rosen Law Firm Encourages Apimeds Pharmaceuticals US, Inc. Investors to Inquire About Securities Class Action Investigation – APUS

Lastest from Businesswire - Thu, 04/16/2026 - 11:14
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) resulting from allegations that Apimeds may have issued materially misleading business information to the investing public. So what: If you purchased Apimeds securities you may be entitled to compensation without payment of any out of pocket fees or costs through a continge

Pages